Table 2.
Summary of potential biomarkers.
| Metabolites | Model groupa | QSHY groupb | |
|---|---|---|---|
| Serum | Tetradecanoic acid | ↑∗∗ | ↓ |
| Oleic acid | ↑∗∗ | ↓ | |
| Glycerol | ↑∗∗ | ↓ | |
| Glycine | ↓∗∗ | ↑## | |
| Homoserine | ↓∗∗ | ↑## | |
| Pyruvic acid | ↓∗∗ | ↑# | |
| Docosahexaenoic acid | ↓∗∗ | ↑ | |
| Ribose | ↓∗∗ | ↑ | |
| Adenine | ↓∗∗ | ↑# | |
| beta-Alanine | ↓∗∗ | ↑## | |
| N-Acetylglutamic acid | ↓∗∗ | ↑## | |
| Myo-inositol | ↓∗∗ | ↑ | |
| 3-Phosphoglyceric acid | ↓∗ | ↑ | |
| Fumaric acid | ↓∗ | ↑ | |
| Malic acid | ↓∗ | ↑# | |
| Adenosine | ↓∗ | ↑# | |
| Glutaric acid | ↓∗ | ↑# | |
| Glyceric acid | ↓∗ | ↑ | |
| Glycerol-2-phosphate | ↓∗ | ↑# | |
| Aspartic acid | ↓∗ | ↑# | |
|
| |||
| Liver tissue | Tetradecanoic acid | ↑∗∗ | ↓ |
| Oleic acid | ↑∗∗ | ↓ | |
| Glycerol | ↑∗∗ | ↓ | |
| Glycine | ↓∗∗ | ↑## | |
| Cholesterol | ↑∗∗ | ↓## | |
| N-Acetylglutamic acid | ↓∗∗ | ↑## | |
| Campesterol | ↓∗∗ | ↑## | |
| Glutaric acid | ↓∗∗ | ↑## | |
| 4-Aminobutyric acid | ↓∗ | ↑## | |
| Adenosine | ↓∗ | ↑# | |
| Adenine | ↓∗∗ | ↑# | |
| Pyruvic acid | ↓∗∗ | ↑# | |
| Glycerol-2-phosphate | ↓∗ | ↑# | |
| Ribose | ↓∗∗ | ↑# | |
| Docosahexaenoic acid | ↓∗∗ | ↑ | |
| Myo-inositol | ↓∗ | ↑ | |
| 3-Phosphoglyceric acid | ↓∗ | ↑ | |
| Malic acid | ↓∗ | ↑ | |
| Fumaric acid | ↓∗ | ↑ | |
The up or down arrows represent the relatively increased or decreased levels of the metabolites in model group or QSHY group, respectively. aCompared to the control group. bCompared to the model group. ∗∗P < 0.01, ∗P < 0.05, ##P < 0.01, and #P < 0.05.